| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.95 | 0.002 | 0.95 | Vasodilator, peripheral | 0.934 0.002 DBMET02216 | ||
| 0.944 | 0 | 0.944 | Prostaglandin F2 alpha agonist | 0.762 0 DBMET02216 | ||
| 0.881 | 0 | 0.881 | Prostaglandin agonist | 0.812 0 DBMET02216 | ||
| 0.876 | 0 | 0.876 | Prostaglandin E2 agonist | 0.829 0 DBMET02216 | ||
| 0.864 | 0.004 | 0.89 | Platelet antagonist | 0.89 0.004 DBMET02216 | DBMET02216 | |
| 0.826 | 0.004 | 0.826 | Antithrombotic | 0.815 0.004 DBMET02216 | ||
| 0.778 | 0.001 | 0.828 | Prostaglandin F2 alpha antagonist | 0.828 0.001 DBMET02216 | DBMET02216 | |
| 0.71 | 0.005 | 0.71 | Spasmolytic | 0.631 0.01 DBMET02216 | ||
| 0.692 | 0.001 | 0.825 | Prostaglandin EP4 antagonist | 0.825 0.001 DBMET02216 | DBMET02216 | |
| 0.66 | 0.002 | 0.723 | Prostaglandin EP2 antagonist | 0.723 0.002 DBMET02216 | DBMET02216 | |
| 0.654 | 0.005 | 0.702 | Platelet aggregation inhibitor | 0.702 0.005 DBMET02216 | DBMET02216 | |
| 0.652 | 0.003 | 0.76 | Prostaglandin antagonist | 0.76 0.003 DBMET02216 | DBMET02216 | |
| 0.657 | 0.012 | 0.657 | Cholesterol antagonist | 0.653 0.012 DBMET02216 | ||
| 0.633 | 0.005 | 0.637 | Vasodilator | 0.637 0.005 DBMET02216 | DBMET02216 | |
| 0.626 | 0 | 0.626 | Prostaglandin EP2 agonist | 0.568 0 DBMET02216 | ||
| 0.611 | 0.003 | 0.627 | Gastric antisecretory | 0.627 0.002 DBMET02216 | DBMET02216 | |
| 0.545 | 0.009 | 0.545 | Hypolipemic | 0.53 0.01 DBMET02216 | ||
| 0.521 | 0.004 | 0.521 | Hemostatic | 0.514 0.004 DBMET02216 | ||
| 0.51 | 0 | 0.51 | Prostaglandin EP4 agonist | 0.491 0 DBMET02216 | ||
| 0.54 | 0.039 | 0.55 | Transcription factor NF kappa B inhibitor | 0.55 0.038 DBMET02216 | DBMET02216 | |
| 0.503 | 0.003 | 0.549 | Prostaglandin E2 antagonist | 0.549 0.003 DBMET02216 | DBMET02216 | |
| 0.493 | 0.003 | 0.551 | Prostaglandin EP1 antagonist | 0.551 0.002 DBMET02216 | DBMET02216 | |
| 0.51 | 0.03 | 0.523 | Immunosuppressant | 0.523 0.027 DBMET02216 | DBMET02216 | |
| 0.471 | 0.001 | 0.502 | Prostaglandin D2 agonist | 0.502 0.001 DBMET02216 | DBMET02216 | |
| 0.452 | 0.002 | 0.484 | Prostaglandin EP3 antagonist | 0.484 0.002 DBMET02216 | DBMET02216 | |
| 0.491 | 0.053 | 0.519 | Cyclophilin D inhibitor | 0.519 0.045 DBMET02216 | DBMET02216 | |
| 0.495 | 0.062 | 0.686 | Caspase 9 stimulant | 0.686 0.026 DBMET02216 | DBMET02216 | |
| 0.41 | 0.004 | 0.5 | Gastrin inhibitor | 0.5 0.003 DBMET02216 | DBMET02216 | |
| 0.41 | 0.01 | 0.433 | Platelet adhesion inhibitor | 0.433 0.009 DBMET02216 | DBMET02216 | |
| 0.396 | 0.002 | 0.589 | Thromboxane antagonist | 0.589 0.002 DBMET02216 | DBMET02216 | |
| 0.378 | 0.002 | 0.578 | Thromboxane A2 antagonist | 0.578 0.002 DBMET02216 | DBMET02216 | |
| 0.384 | 0.01 | 0.397 | Bone formation stimulant | 0.397 0.01 DBMET02216 | DBMET02216 | |
| 0.401 | 0.027 | 0.401 | Hypoglycemic | 0.378 0.031 DBMET02216 | ||
| 0.37 | 0.008 | 0.37 | Insulin sensitizer | 0.339 0.01 DBMET02216 | ||
| 0.457 | 0.107 | 0.467 | Antiinflammatory | 0.467 0.102 DBMET02216 | DBMET02216 | |
| 0.441 | 0.095 | 0.445 | Apoptosis agonist | 0.445 0.093 DBMET02216 | DBMET02216 | |
| 0.362 | 0.017 | 0.362 | Hepatoprotectant | 0.326 0.023 DBMET02216 | ||
| 0.391 | 0.047 | 0.431 | Caspase 3 stimulant | 0.431 0.035 DBMET02216 | DBMET02216 | |
| 0.371 | 0.053 | 0.371 | Immunomodulator | 0.299 0.083 DBMET02216 | ||
| 0.337 | 0.037 | 0.337 | Transcription factor STAT3 inhibitor | 0.242 0.09 DBMET02216 | ||
| 0.277 | 0.002 | 0.315 | Prostacyclin agonist | 0.315 0.002 DBMET02216 | DBMET02216 | |
| 0.284 | 0.013 | 0.347 | Cholesterol synthesis inhibitor | 0.347 0.007 DBMET02216 | DBMET02216 | |
| 0.284 | 0.019 | 0.284 | Protein kinase stimulant | 0.269 0.022 DBMET02216 | ||
| 0.327 | 0.068 | 0.349 | Apoptosis antagonist | 0.349 0.056 DBMET02216 | DBMET02216 | |
| 0.293 | 0.052 | 0.321 | Angiogenesis stimulant | 0.321 0.042 DBMET02216 | DBMET02216 | |
| 0.228 | 0 | 0.393 | Thromboxane agonist | 0.393 0 DBMET02216 | DBMET02216 | |
| 0.291 | 0.08 | 0.347 | Interleukin 2 agonist | 0.347 0.047 DBMET02216 | DBMET02216 | |
| 0.241 | 0.03 | 0.291 | Interferon gamma antagonist | 0.291 0.021 DBMET02216 | DBMET02216 | |
| 0.28 | 0.07 | 0.28 | Antioxidant | 0.279 0.07 DBMET02216 | ||
| 0.293 | 0.085 | 0.344 | Sodium/bile acid cotransporter inhibitor | 0.344 0.044 DBMET02216 | DBMET02216 | |
| 0.286 | 0.083 | 0.286 | Immunostimulant | 0.243 0.099 DBMET02216 | ||
| 0.242 | 0.044 | 0.242 | P-glycoprotein inhibitor | 0.21 0.058 DBMET02216 | ||
| 0.235 | 0.056 | 0.237 | Nitric oxide antagonist | 0.237 0.055 DBMET02216 | DBMET02216 | |
| 0.23 | 0.052 | 0.254 | Non-steroidal antiinflammatory agent | 0.254 0.041 DBMET02216 | DBMET02216 | |
| 0.2 | 0.024 | 0.2 | Toll-Like receptor 2 antagonist | 0.168 0.041 DBMET02216 | ||
| 0.212 | 0.037 | 0.261 | Melanin inhibitor | 0.261 0.027 DBMET02216 | DBMET02216 | |
| 0.202 | 0.035 | 0.255 | ATPase inhibitor | 0.255 0.012 DBMET02216 | DBMET02216 | |
| 0.168 | 0.005 | 0.168 | Peroxisome proliferator-activated receptor alpha agonist | 0.152 0.006 DBMET02216 | ||
| 0.185 | 0.024 | 0.185 | Microtubule formation inhibitor | 0.141 0.043 DBMET02216 | ||
| 0.191 | 0.031 | 0.191 | DNA polymerase I inhibitor | 0.19 0.031 DBMET02216 | ||
| 0.164 | 0.009 | 0.225 | Leukotriene antagonist | 0.225 0.005 DBMET02216 | DBMET02216 | |
| 0.193 | 0.045 | 0.209 | Interleukin 6 antagonist | 0.209 0.036 DBMET02216 | DBMET02216 | |
| 0.19 | 0.043 | 0.199 | Arachidonic acid antagonist | 0.199 0.034 DBMET02216 | DBMET02216 | |
| 0.171 | 0.025 | 0.179 | Bronchodilator | 0.179 0.022 DBMET02216 | DBMET02216 | |
| 0.192 | 0.047 | 0.217 | Phospholipase A2 inhibitor | 0.217 0.035 DBMET02216 | DBMET02216 | |
| 0.175 | 0.032 | 0.175 | Adenylate cyclase inhibitor | 0.156 0.041 DBMET02216 | ||
| 0.172 | 0.033 | 0.203 | Adenylate cyclase stimulant | 0.203 0.012 DBMET02216 | DBMET02216 | |
| 0.139 | 0.004 | 0.227 | Prostacyclin antagonist | 0.227 0.004 DBMET02216 | DBMET02216 | |
| 0.233 | 0.1 | 0.233 | Transcription factor STAT inhibitor | |||
| 0.227 | 0.097 | 0.227 | Interleukin agonist | 0.175 0.144 DBMET02216 | ||
| 0.172 | 0.043 | 0.2 | Neurotrophic factor | 0.2 0.028 DBMET02216 | DBMET02216 | |
| 0.162 | 0.04 | 0.171 | Farnesoid X receptor antagonist | 0.171 0.034 DBMET02216 | DBMET02216 | |
| 0.173 | 0.054 | 0.198 | NOS3 expression enhancer | 0.198 0.042 DBMET02216 | DBMET02216 | |
| 0.135 | 0.016 | 0.146 | Peroxisome proliferator-activated receptor gamma agonist | 0.146 0.014 DBMET02216 | DBMET02216 | |
| 0.137 | 0.021 | 0.144 | ABCA1 expression enhancer | 0.144 0.019 DBMET02216 | DBMET02216 | |
| 0.14 | 0.027 | 0.14 | Toll-Like receptor 4 antagonist | 0.138 0.028 DBMET02216 | ||
| 0.117 | 0.004 | 0.117 | Nitric oxide donor | 0.114 0.004 DBMET02216 | ||
| 0.115 | 0.008 | 0.182 | Leukotriene B4 antagonist | 0.182 0.004 DBMET02216 | DBMET02216 | |
| 0.165 | 0.062 | 0.199 | Hexokinase inhibitor | 0.199 0.036 DBMET02216 | DBMET02216 | |
| 0.12 | 0.02 | 0.126 | ATPase (Vacuolar H+) inhibitor | 0.126 0.016 DBMET02216 | DBMET02216 | |
| 0.196 | 0.105 | 0.205 | Peptidyltransferase inhibitor | 0.205 0.093 DBMET02216 | DBMET02216 | |
| 0.241 | 0.156 | 0.271 | Toll-Like receptor agonist | 0.271 0.13 DBMET02216 | DBMET02216 | |
| 0.127 | 0.043 | 0.146 | AMP-activated protein kinase stimulant | 0.146 0.031 DBMET02216 | DBMET02216 | |
| 0.232 | 0.152 | 0.232 | Vasodilator, coronary | |||
| 0.133 | 0.06 | 0.147 | Vanilloid 1 agonist | 0.147 0.042 DBMET02216 | DBMET02216 | |
| 0.103 | 0.036 | 0.103 | Transcription factor NF kappa B stimulant | 0.093 0.046 DBMET02216 | ||
| 0.185 | 0.123 | 0.185 | Tumour necrosis factor alpha release inhibitor | |||
| 0.167 | 0.106 | 0.172 | Interleukin antagonist | 0.172 0.102 DBMET02216 | DBMET02216 | |
| 0.075 | 0.014 | 0.114 | Thromboxane synthase inhibitor | 0.114 0.005 DBMET02216 | DBMET02216 | |
| 0.11 | 0.05 | 0.128 | Anabolic | 0.128 0.032 DBMET02216 | DBMET02216 | |
| 0.062 | 0.005 | 0.068 | HMG CoA reductase inhibitor | 0.068 0.004 DBMET02216 | DBMET02216 | |
| 0.077 | 0.03 | 0.077 | Exportin-1 inhibitor | |||
| 0.091 | 0.046 | 0.096 | Vanilloid agonist | 0.096 0.038 DBMET02216 | DBMET02216 | |
| 0.045 | 0.007 | 0.085 | Prostaglandin D2 antagonist | 0.085 0.005 DBMET02216 | DBMET02216 | |
| 0.165 | 0.128 | 0.165 | Free radical scavenger | 0.164 0.13 DBMET02216 | ||
| 0.059 | 0.024 | 0.059 | Lysophosphatidic acid 3 receptor antagonist | 0.059 0.023 DBMET02216 | ||
| 0.048 | 0.013 | 0.053 | Peroxisome proliferator-activated receptor delta agonist | 0.053 0.011 DBMET02216 | DBMET02216 | |
| 0.159 | 0.125 | 0.164 | Neurotrophic factor enhancer | 0.164 0.118 DBMET02216 | DBMET02216 | |
| 0.176 | 0.144 | 0.176 | Cardiotonic | |||
| 0.034 | 0.003 | 0.06 | Thromboxane A2 agonist | 0.06 0.002 DBMET02216 | DBMET02216 | |
| 0.073 | 0.043 | 0.073 | Elastase 1 inhibitor | |||
| 0.034 | 0.003 | 0.039 | Vitamin D receptor agonist | 0.039 0.003 DBMET02216 | DBMET02216 | |
| 0.041 | 0.012 | 0.041 | Cholesterol ester transfer protein antagonist | |||
| 0.053 | 0.024 | 0.053 | Microtubule stabilization | 0.045 0.035 DBMET02216 | ||
| 0.082 | 0.056 | 0.082 | Antineoplastic antibiotic | 0.078 0.058 DBMET02216 | ||
| 0.058 | 0.034 | 0.072 | Leukotriene C antagonist | 0.072 0.012 DBMET02216 | DBMET02216 | |
| 0.072 | 0.049 | 0.072 | Peroxisome proliferator-activated receptor gamma antagonist | 0.069 0.055 DBMET02216 | ||
| 0.061 | 0.038 | 0.065 | Sphingosine kinase inhibitor | 0.065 0.031 DBMET02216 | DBMET02216 | |
| 0.028 | 0.008 | 0.03 | Vitamin D receptor antagonist | 0.03 0.007 DBMET02216 | DBMET02216 | |
| 0.031 | 0.012 | 0.051 | Prostaglandin H2 antagonist | 0.051 0.004 DBMET02216 | DBMET02216 | |
| 0.038 | 0.019 | 0.038 | Squalene synthetase inhibitor | |||
| 0.124 | 0.105 | 0.127 | Insulin secretagoues | 0.127 0.101 DBMET02216 | DBMET02216 | |
| 0.058 | 0.041 | 0.058 | Lipocortins synthesis agonist | 0.058 0.04 DBMET02216 | ||
| 0.053 | 0.037 | 0.053 | Protein 50S ribosomal subunit inhibitor | 0.052 0.038 DBMET02216 | ||
| 0.036 | 0.019 | 0.036 | Calcium-independent phospholipase A2 inhibitor | 0.035 0.022 DBMET02216 | ||
| 0.208 | 0.192 | 0.266 | Toll-Like receptor 7 agonist | 0.266 0.134 DBMET02216 | DBMET02216 | |
| 0.131 | 0.12 | 0.135 | Antipruritic | 0.135 0.113 DBMET02216 | DBMET02216 | |
| 0.024 | 0.013 | 0.033 | Leukotriene B4 receptor 2 antagonist | 0.033 0.007 DBMET02216 | DBMET02216 | |
| 0.061 | 0.051 | 0.061 | Neuraminidase (influenza) inhibitor | |||
| 0.07 | 0.06 | 0.077 | Na+ K+ transporting ATPase inhibitor | 0.077 0.053 DBMET02216 | DBMET02216 | |
| 0.099 | 0.09 | 0.109 | TRPA1 agonist | 0.109 0.073 DBMET02216 | DBMET02216 | |
| 0.13 | 0.122 | 0.137 | Ca2+-transporting ATPase inhibitor | 0.137 0.087 DBMET02216 | DBMET02216 | |
| 0.138 | 0.134 | 0.183 | Phospholipase C inhibitor | 0.183 0.058 DBMET02216 | DBMET02216 | |
| 0.011 | 0.008 | 0.011 | Calcineurin inhibitor | 0.011 0.008 DBMET02216 | ||
| 0.025 | 0.022 | 0.042 | Leukotriene B4 receptor 1 antagonist | 0.042 0.01 DBMET02216 | DBMET02216 | |
| 0.037 | 0.034 | 0.048 | Leukotriene C4 antagonist | 0.048 0.012 DBMET02216 | DBMET02216 | |
| 0.172 | 0.174 | 0.213 | Lipoxygenase inhibitor | 0.213 0.127 DBMET02216 | DBMET02216 | |
| 0.056 | 0.062 | 0.081 | Leukotriene synthesis inhibitor | 0.081 0.037 DBMET02216 | DBMET02216 | |
| 0.051 | 0.058 | 0.059 | Selectin antagonist | 0.059 0.051 DBMET02216 | DBMET02216 | |
| 0.04 | 0.05 | 0.045 | Parathyroid hormone antagonist | 0.045 0.031 DBMET02216 | DBMET02216 | |
| 0.098 | 0.122 | 0.114 | Interleukin 4 antagonist | 0.114 0.094 DBMET02216 | DBMET02216 | |
| 0.074 | 0.098 | 0.079 | T cell inhibitor | 0.079 0.072 DBMET02216 | DBMET02216 | |
| 0.073 | 0.1 | 0.095 | Sphingomyelinase inhibitor | 0.095 0.065 DBMET02216 | DBMET02216 | |
| 0.007 | 0.036 | 0.021 | G-protein-coupled receptor 120 agonist | 0.021 0.008 DBMET02216 | DBMET02216 | |
| 0.061 | 0.09 | 0.089 | Ornithine decarboxylase inhibitor | 0.089 0.057 DBMET02216 | DBMET02216 | |
| 0.109 | 0.141 | 0.152 | Growth hormone agonist | 0.152 0.086 DBMET02216 | DBMET02216 | |
| 0.074 | 0.107 | 0.099 | Expectorant | 0.099 0.069 DBMET02216 | DBMET02216 | |
| 0.087 | 0.124 | 0.108 | Aldehyde dehydrogenase inhibitor | 0.108 0.085 DBMET02216 | DBMET02216 | |
| 0.042 | 0.083 | 0.054 | Sphingosine 1-phosphate receptor 5 agonist | 0.054 0.036 DBMET02216 | DBMET02216 | |
| 0.117 | 0.174 | 0.147 | Lipocortins synthesis antagonist | 0.147 0.109 DBMET02216 | DBMET02216 | |
| 0.071 | 0.139 | 0.103 | Mucolytic | 0.103 0.074 DBMET02216 | DBMET02216 | |
| 0.05 | 0.135 | 0.075 | Keratolytic | 0.075 0.056 DBMET02216 | DBMET02216 | |
| 0.029 | 0.115 | 0.048 | Glucose-6-phosphate isomerase inhibitor | 0.048 0.033 DBMET02216 | DBMET02216 | |
| 0.069 | 0.165 | 0.104 | Adenylate kinase inhibitor | 0.104 0.061 DBMET02216 | DBMET02216 | |
| 0.068 | 0.181 | 0.117 | Thrombolytic | 0.117 0.114 DBMET02216 | DBMET02216 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |